These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33978906)

  • 21. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective.
    Jendle J; Ericsson Å; Ekman B; Sjöberg S; Gundgaard J; da Rocha Fernandes J; Mårdby AC; Hunt B; Malkin SJP; Thunander M
    J Med Econ; 2020 Nov; 23(11):1311-1320. PubMed ID: 32746676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Which people with diabetes are treated with a disposable, half-unit insulin pen? A real-world, retrospective, database study in Spain.
    Ampudia-Blasco FJ; Duque N; Artime E; Caveda E; Spaepen E; Díaz-Cerezo S; de Santos MR; Velasco DC; Bahíllo-Curieses MP
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e451. PubMed ID: 37715339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating Hypoglycemic Confidence in Type 1 and Type 2 Diabetes.
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Diabetes Technol Ther; 2017 Feb; 19(2):131-136. PubMed ID: 27997217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
    Billings LK; Parkin CG; Price D
    Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes.
    Cusi K; Sanyal AJ; Zhang S; Hoogwerf BJ; Chang AM; Jacober SJ; Bue-Valleskey JM; Higdon AN; Bastyr EJ; Haupt A; Hartman ML
    Diabetes Obes Metab; 2016 Oct; 18 Suppl 2():50-58. PubMed ID: 27723227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events.
    Farmer A; Balman E; Gadsby R; Moffatt J; Cradock S; McEwen L; Jameson K
    Curr Med Res Opin; 2008 Nov; 24(11):3097-104. PubMed ID: 18828957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysis.
    Joshi SR; Singh G; Marwah A; Mittra S; Suvarna VR; Athalye SN
    Diabetes Obes Metab; 2023 Jun; 25(6):1589-1606. PubMed ID: 36748186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy.
    Haldrup S; Lapolla A; Gundgaard J; Wolden ML
    J Med Econ; 2020 Mar; 23(3):271-279. PubMed ID: 31526202
    [No Abstract]   [Full Text] [Related]  

  • 30. A survey of physician experience and treatment satisfaction using fast-acting insulin aspart in people with type 1 or type 2 diabetes.
    Baru A; Amir S; Ekelund M; Montagnoli R; Da Rocha Fernandes JD
    Postgrad Med; 2020 May; 132(4):320-327. PubMed ID: 32306819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-density lipoprotein subspecies between patients with type 1 diabetes and type 2 diabetes without / with intensive insulin therapy.
    Fukui T; Hirano T
    Endocr J; 2012; 59(7):561-9. PubMed ID: 22504174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials.
    Rosenstock J; Marre M; Qu Y; Zhang S; Bastyr EJ; Prince MJ; Chang AM
    Diabetes Obes Metab; 2016 Nov; 18(11):1093-1097. PubMed ID: 27484021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study.
    Abitbol A; Brown RE; Jiandani D; Sauriol L; Aronson R
    Can J Diabetes; 2019 Oct; 43(7):504-509.e1. PubMed ID: 31256905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
    Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
    J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
    Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The continuous spectrum of glycaemic variability changes with pancreatic islet function: A multicentre cross-sectional study in China.
    Zhang L; Guo K; Tian Q; Ye J; Ding Z; Zhou Q; Wu J; Fan L; Pan N; Niu X; Zhao Q; Ma Y; Jiang H; Huang G; Li X; Zhou Z; Yang L
    Diabetes Metab Res Rev; 2022 Nov; 38(8):e3579. PubMed ID: 36214297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Portrait of women with type 1 or type 2 diabetes of childbearing age attending diabetes clinics in Italy: the AMD-Annals initiative.
    Scavini M; Rossi MC; Scardapane M; Nicolucci A; Manicardi V; Russo G; Di Bartolo P; Giorda CB; Musacchio N; Ceriello A; Genovese S; Molinari C; Dozio N;
    Acta Diabetol; 2018 Feb; 55(2):193-199. PubMed ID: 29209815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initiation of Continuous Glucose Monitoring Is Linked to Improved Glycemic Control and Fewer Clinical Events in Type 1 and Type 2 Diabetes in the Veterans Health Administration.
    Reaven PD; Newell M; Rivas S; Zhou X; Norman GJ; Zhou JJ
    Diabetes Care; 2023 Apr; 46(4):854-863. PubMed ID: 36807492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.